OP Asset Management Ltd bought a new position in Humana Inc. (NYSE:HUM – Free Report) during the first quarter, according to its most recent disclosure with the SEC. The firm bought 12,145 shares of the insurance provider’s stock, valued at approximately $2,106,000.
Several other hedge funds have also bought and sold shares of HUM. Montag A & Associates Inc. lifted its position in shares of Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares in the last quarter. CoreCap Advisors LLC increased its holdings in Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac bought a new stake in Humana during the 4th quarter worth approximately $27,000. Reflection Asset Management purchased a new position in Humana during the fourth quarter valued at approximately $29,000. Finally, Rosenberg Matthew Hamilton lifted its holdings in Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 68 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.
Wall Street Analysts Forecast Growth
HUM has been the subject of a number of analyst reports. Wolfe Research raised shares of Humana from a “hold” rating to a “strong-buy” rating in a research note on Thursday, June 4th. JPMorgan Chase & Co. lifted their target price on shares of Humana from $214.00 to $316.00 and gave the company a “neutral” rating in a research note on Monday, June 8th. Leerink Partners upped their target price on shares of Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a report on Thursday, April 30th. Barclays increased their price target on Humana from $180.00 to $344.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 26th. Finally, Raymond James Financial reissued an “outperform” rating and set a $260.00 price target on shares of Humana in a report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $293.09.
Humana Stock Up 0.1%
Shares of HUM stock opened at $384.19 on Monday. The stock has a market cap of $46.13 billion, a P/E ratio of 41.09, a PEG ratio of 2.19 and a beta of 0.76. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $385.49. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The company’s fifty day simple moving average is $303.11 and its two-hundred day simple moving average is $245.65.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same quarter last year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Analysts predict that Humana Inc. will post 9.04 EPS for the current fiscal year.
Humana Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is currently 37.86%.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Read More
- Five stocks we like better than Humana
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
